Topical treatment with nerve growth factor in an animal model of herpetic keratitis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 246, Issue 1, 2008, Pages 121-127

  Lambiase, Alessandro ^a   Coassin, Marco ^a   Costa, Nicola ^c   Lauretti, Paolo ^a   Micera, Alessandra ^a,b   Ghinelli, Emiliano ^a   Aloe, Luigi ^d   Rama, Paolo ^e   Bonini, Stefano ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Antiviral therapy; Herpes simplex virus; Herpetic keratitis; Nerve growth factor

Indexed keywords

ACICLOVIR; BALANCED SALT SOLUTION; GLYCOPROTEIN D; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR ANTIBODY; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RABBIT; SLIT LAMP; VIRUS REPLICATION; VIRUS STRAIN;

ACYCLOVIR; ADMINISTRATION, TOPICAL; ANIMALS; ANTIBODIES, BLOCKING; ANTIVIRAL AGENTS; CYTOPROTECTION; DISEASE MODELS, ANIMAL; FEMALE; HERPESVIRUS 1, HUMAN; IMMUNOENZYME TECHNIQUES; KERATITIS, HERPETIC; NERVE GROWTH FACTOR; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RABBITS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 36448929774     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0593-6     Document Type: Article

References (57)

1. Akbar AN, Lord JM, Salmon M (2000) IFN-alpha and IFN-beta: A link between immune memory and chronic inflammation. Immunol Today 21:337-342
2. Akova YA, Onat M, Duman S (1999) Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex heratitis. Ocul Immunol Inflamm 7:51-60
3. Aloe L (1987) Intraocular herpes simplex virus injection in neonatal rats induces sympathetic nerve cell destruction: Effect of nerve growth factor. Int J Dev Neurosci 5:357-366
4. Anand BS, Hill JM, Dey S, Maruyama K, Bhattacharjee PS, Myles ME, Nashed YE, Mitra AK (2003) In vivo antiviral efficacy of a dipeptide Acyclovir prodrug, val-val-Acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model. IOVS 44:2529-2534
5. Arffa RC (1991) Epithelial diseases. In: Arffa RC (ed.) Grayson's diseases of the cornea, 3rd edn. Mosby Inc, St. Louis
6. Aurelius E, Johansson B, Skoldenberg B, Staland A, Forsgren M (1991) Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet 337:189-192
7. Barney NP, Foster CS (1994) A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea 13:232-236
8. Barouch R, Kazimirsky G, Appel E, Brodie C (2001) Nerve growth factor regulates TNF-alpha production in mouse macrophages via MAP kinase activation. J Leukoc Biol 69:1019-1026
9. Biswas S, Suresh P, Bonshek RE, Corbitt G, Tullo AB, Ridgway AE (2000) Graft failure in human donor corneas due to transmission of herpes simplex virus. Br J Ophthalmol 84:701-705
10. Bocchini V, Angeletti PU (1969) The nerve growth factor: Purification as a 30,000-molecular-weight protein. Proc Natl Acad Sci USA 64:787-794
11. Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L (2000) Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 107:1347-1351
12. Bonneau RH, Sheridan JF, Feng N, Glaser R (1991) Stress-induced suppression of herpes simplex virus (HSV)-specific cytotoxic T lymphocyte and natural killer cell activity and enhancement of acute pathogenesis following local HSV infection. Brain Behav Immun 5:170-192
13. Coassin M, Lambiase A, Costa N, De Gregorio A, Sgrulletta R, Sacchetti M, Aloe L, Bonini S (2005) Efficacy of topical nerve growth factor treatment in dogs affected by dry eye. Graefes Arch Clin Exp Ophthalmol 243:151-155
14. Cocchi F, Fusco D, Menotti L, Gianni T, Eisenberg RJ, Cohen GH, Campanelli-Fiume G (2004) The solubile ectodomain of herpes simplex virus gD contains a membrane-proximal pro-fusion domain and suffices to mediate virus entry. Proc Natl Acad Sci USA 101:7445-7450
15. Cockerham G (2001) Primary graft failure caused by herpes simplex virus type 1. Cornea 20:774-775
16. Cook ML, Bastone VB, Stevens JG (1974) Evidence that neurons harbor latent herpes simplex virus. Infect Immun 9:946-951
17. Cook SD (1992) Herpes simplex virus in the eye. Br J Ophthalmol 76:365-366
18. De Maria A, Tundo P, Romano A, Grima P (1995) Anti-HSV-1 herpes vaccination by LUPIDON H: Preliminary results. Adv Exp Med Biol 371B:1599-1600
19. Dicou E, Nerriere V, Labropoulou V (1991) Naturally occurring antibodies against nerve growth factor in human and rabbit sera: Comparison between control and herpes simplex virus-infected patients. J Neuroimmunol 34:153-158
20. Ehrhard PB, Ganter U, Stalder A, Bauer J, Otten U (1993) Expression of functional trk protooncogene in human monocytes. Proc Natl Acad Sci USA 90:5423-5427
21. Gee AP, Boyle MD, Munger KL, Lawman MJ, Young M (1983) Nerve growth factor: Stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc Natl Acad Sci USA 80:7215-7218
22. Heise MT, Virgin HW (1995) The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J Virol 69:904-909
23. Herpetic Eye Disease Study Group (2000) Oral acyclovir for herpes simplex virus eye disease: Effect on prevention of epithelial keratitis and stromal keratitis. Arch Ophthalmol 118:1030-1036
24. Hill JM, Garza HH Jr, Helmy MF, Cook SD, Osborne PA, Johnson EM Jr, Thompson HW, Green LC, O'Callaghan RJ, Gebhardt BM (1997) Nerve growth factor antibody stimulates reactivation of ocular herpes simplex virus type 1 in latently infected rabbits. J Neurovirology 3:206-211
25. Johnson GL, Limon L, Trikha G, Wall H (1994) Acute renal failure and neurotoxicity following oral acyclovir. Ann Pharmacother 28:460-463
26. Lalani AS, Barrett JW, McFadden G (2000) Modulating chemokines: More lessons from viruses. Immunol Today 21:100-106
27. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L (1998) Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 338:1174-1180
28. Lambiase A, Manni L, Bonini S, Rama P, Micera A, Aloe L (2000) Nerve growth factor promotes corneal healing: Structural, biochemical, and molecular analyses of rat and human corneas. Invest Ophthalmol Vis Sci 41:1063-1069
29. Lambiase A, Bonini S, Rama P, Bonini S, Aloe L (2000) Antiinflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting. Arch Ophthalmol 118:1446-1449
30. Laycock KA, Brady RH, Lee SF, Osborne PA, Johnson EM, Pepose JS (1994) The role of nerve growth factor in modulating herpes simplex virus reactivation in vivo. Graefes Arch Clin Exp Ophthalmol 232:421-425
31. Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237:1154-1162
32. Levi-Montalcini R, Aloe L, Alleva E (1990) A role for nerve growth factor in nervous, endocrine and immune system. Progress In Neuroendocrinimmunology 3:1-10
33. Matsuda H, Coughlin MD, Bienenstock J, Denburg JA (1988) Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc Natl Acad Sci USA 85:6508-6512
34. McLennan JL, Darby G (1980) Herpes simplex virus latency: The cellular location of virus in dorsal root ganglia and the fate of the infected cell following activation. J Gen Virol 51:233-243
35. Moyes AL, Sugar A, Musch DC, Barnes RD (1994) Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis. Arch Ophthalmol 112:601-607
36. Nja A, Purves D (1978) The effects of nerve growth factor and its antiserum on synapses in the superior cervical ganglion of the guinea-pig. J Physiol 277:53-75
37. Otten U, Ehrhard P, Peck R (1989) Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci USA 86:10059-10063
38. Perry AK, Chen G, Zheng D, Tang H, Cheng G (2005) The host type I interferon response to viral and bacterial infections. Cell Res 15:407-422
39. Pivetti-Pezzi P, Accorinti M, Colabelli-Gisoldi RA, Pirraglia MP, Sirianni MC (1999) Herpes simplex virus vaccine in recurrent herpetic ocular infection. Cornea 18:47-51
40. Price RW, Schmitz J (1978) Reactivation of latent herpes simplex virus infection in autonomic nervous system by postganglionic neurectomy. Infect Immun 19:523-532
41. Purves D, Nja A (1976) Effect of nerve growth factor on synaptic depression following axotomy. Nature 260:535-536
42. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson D (1993) Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 262:695-700
43. Rajcani J, Vojvodova A (1998) The role of herpes simplex glycoproteins in the virus replication cycle. Acta Virol 42:103-118
44. Remeijer L, Osterhaus A, Verjans G (2004) Human herpes simplex virus keratitis: The pathogenesis revisited. Ocul Immunol Inflamm 12:255-285
45. Sawtell NM, Thompson RL (1992) Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J Virol 66:2150-2156
46. Sedgwick JD, Riminton DS, Cyster JG, Korner H (2000) Tumor necrosis factor: A master-regulator of leukocyte movement. Immunol Today 21:110-113
47. Smith RL, Pizer LI, Johnson EM Jr, Wilcox CL (1992) Activation of second-messenger pathways reactivates latent herpes simplex virus in neuronal cultures. Virol 188:311-318
48. Tambasco FP, Cohen EJ, Nguyen LH, Rapuano CJ, Laibson PR (1999) Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Arch Ophthalmol 117:445-449
49. The Herpetic Eye Disease Study Group (1998) Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 339:300-306
50. Thoenen H, Barde YA (1980) Physiology of nerve growth factor. Physiol Rev 60:1284-1335
51. Thorpe LW, Perez-Polo JR (1987) The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes. J Neurosci Res 18:134-139
52. Ungheri D, Verini MA, Ganceff L, Mazue G, Carminati P (1993) Antiviral activity of nerve growth factor in vitro. Drugs Exp Clin Res 19:151-157
53. Vandepapeliere P (2002) Therapeutic vaccination against chronic viral infections. Lancet Infect Dis 2:353-367
54. Walz MA, Price RW, Notkins AL (1974) Latent ganglionic infection with herpes simplex virus types 1 and 2: Viral reactivation in vivo after neurectomy. Science 184:1185-1187
55. Wilcox CL, Johnson EM (1987) Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro. J Virol 61:2311-2315
56. Wilcox CL, Johnson EM Jr (1988) Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro. J Virol 62:393-399
57. Wilcox CL, Smith RL, Freed CR, Johnson EM Jr (1990) Nerve growth factor-dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. J Neurosci 10:1268-1275